Filing Details
- Accession Number:
- 0001179110-16-021548
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-11 16:47:38
- Reporting Period:
- 2016-03-09
- Filing Date:
- 2016-03-11
- Accepted Time:
- 2016-03-11 16:47:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1199632 | J William Bolt | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Svp, Qa And Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par | Acquisiton | 2016-03-09 | 7,156 | $13.80 | 97,561 | No | 4 | M | Direct | |
Common Stock, $.01 Par | Disposition | 2016-03-09 | 20,076 | $85.57 | 77,485 | No | 4 | S | Direct | |
Common Stock, $.01 Par | Disposition | 2016-03-09 | 4,456 | $85.11 | 73,029 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2016-03-09 | 7,156 | $0.00 | 7,156 | $13.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-05-23 | 2018-05-23 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 5,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 6,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2022-05-22 | 0 | 5,000 | Direct |
2023-05-14 | 0 | 20,000 | Direct |
2024-05-14 | 0 | 15,000 | Direct |
2025-05-13 | 0 | 6,000 | Direct |
Footnotes
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $85.0000 and $85.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $86.0000 and $86.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.